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1. Introduction
  Color Doppler ultrasound technique is a important way 
to diagnose cirrhosis and the standard of diagnosis of 
cirrhosis is that the diameters of the portal vein (PV) and 
splenic vein (SV) are respectively more than 13 mm and 
8 mm[1]. Vasoactive substances mediate and participate 
in the formation of cirrhosis portal hypertension and the 
correlation between the content of vasoactive substances 
and cirrhosis as well as portal hemodynamics attracts a 
lot of attention[2]. Abnormal hemodynamics of cirrhosis is 
related to multiple vasoactive substances such as tumor 
necrosis factor, substance-P, vasoactive intestinal peptide, 
prostacyclin, endothelin (ET) and nitric oxide (NO) and so 
on[3]. Among these substances, ET is a kind of polypeptide 
consisting of 21 amino acids with a strong function of 
vascular contraction. ET-1 is synthesized by vascular 
endothelial cells[4] and plays an important biological role in 
liver and the portal system. The application of ET receptor 
antagonists can reduce the portal pressure[5]. Calcitonin 
gene-related peptide (CGRP) and calcitonin (Cal) come from 
a same gene and CGRP, consisting of 37 amino acids, is 
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a kind of vasoactive peptide and can dilate the peripheral 
vessel remarkably[6]. Hemodynamic change of parameters in 
liver of patients with cirrhosis was detected by Color Doppler 
ultrasound technique and the change in the contents of 
vasoactive substances ET-1 and CGRP was checked by 
radioimmanoassay.
2. Materials and Methods 
2.1. General Materials
  A total of 178 patients who came to our hospital during Sep. 
2009 to Sep. 2011 and were diagnosed with cirrhosis were 
chosen as study group, among whom there were 128 male 
cases and 50 female cases in the range of age 20-62 years 
old with the average age of (37.8依17.5) years. According 
to child-pugh grade of liver function, there were 55 cases 
with grade A, 89 cases with grade B and 34 cases with grade 
C. There were 106 cases with ascites and 72 cases without 
ascites. There were 144 cases with hepatitis cirrhosis, 13 
cases with schistosomiasis cirrhosis, 8 cases with alcoholic 
cirrhosis and 13 cases with mixed cirrhosis. A total of 60 
healthy persons were chosen as control group and they 
matched with the study group in terms of characters such as 
age fabric.
2.2. Ultrasonic diagnosis
  Cases should be on fasting for 12 h before examination 
and be in resting in supine position. Toshiba Aplio500 Color 
Doppler ultrasound diagnostic apparatus was used with 
probe frequency 2.5-4.0 MHz to measure the diameter of 
portal vein (Dpv), velocity of portal vein (Vpv), diameter of 
splenic vein (Dsv), velocity of splenic vein (Vsv), quantity 
of portal vein (Qpv), quantity of splenic vein (Qsv). The 
calculation formula of venous quantity was Q=Vmin伊(D/2)2
伊毿伊60 (Q was short for blood quantity, D symbolized the 
diameter of portal vein and Vmin symbolized the average 
velocity of blood).
2.3. Detection of vasoactive substances in serum
    After cases who received examination finished their fast 
of 12 h, 8 mL blood was collected from them with empty 
stomach in the morning. And 4 mL was sent to be checked 
for liver function and the rest was divided into halves, 
stored in two test tubes respectively. Each tube contained 
0.3 M anticoagulant EDTA-Na2 20 毺L, 0.32 M dimercaprol 
dimercaptopropanol 10 毺L and 0.34 M 8- hydroxyquinoline 
sulfate 20 毺L. After they were fully mixed, the solution 
was centrifugal for 10 min at 2 000 rpm. The separated 
plasma was kept at -20 曟 to detect ET-1 and CGRP. 
Radioimmunoassay kits of ET-1 and CGRP were bought from 
Beijing S & P Weiye Biological Technology Co. Ltd. and the 
operations were strictly under the guidance of instructions. 
   
2.4. Statistical analysis
  Software MATLAB 7.0 was used to analyze the statistics. 
Measurement data were symbolized by the means依standard 
deviations. The comparison of the differences in means of 
different samples was analyzed by variance and checked by 
t, regarding 毩=0.05 as checking standard. The difference 
was statistically meaningful when P﹤0.05.
3. Results 
3.1. Results of color Doppler ultrasound diagnosis 
  Considering the final analyzed results, the Dpv and Dsv 
was wider than that in healthy group (P﹤0.05), Vsv was 
increased but the difference was not significant (P>0.05), 
Qsv was increased significantly (P﹤0.01) and the value of 
Qsv/Qpv was significantly larger than that in control group. 
From the perspective of Child-Pugh grade of liver function 
which reflected the degree of cirrhosis, in an ascending 
order A, B and C, Dpv and Dsv were increased gradually and 
there was significantly difference between adjacent groups 
(P﹤0.05). Vpv was gradually decreased (P﹤0.05). The change 
of Vsv in different groups wasn’t significant (P>0.05). The 
difference of Qpv between adjacent groups wasn’t significant 
either (P>0.05). Qsv was significantly in a increasing trend 
(P﹤0.01) and so it was same with the value of Qsv/Qpv, and the 
differences among groups were significantly (P﹤0.01) (Table 1).  
3.2. Detection of ET-1 and CGRP
  Radioimmunoassay was used to detect the content of ET-1 
and CGRP in serum. The results showed the levels of them 
in study group were significantly higher than that in control 
group (P﹤0.01), the levels of them in group with ascites 
were significantly higher than that in group without ascites 
(P﹤0.05 or P﹤0.01). The difference between the levels of 
ET-1 and CGRP in group without ascites and that in control 
group wasn’t significant (P>0.05) (Table 2). 
3.3. Relation between the degree of damage to liver function 
and the levels of ET-1 and CGRP in plasma
  The detected results showed that there was no significant 
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difference between the levels of ET-1 and CGRP in group 
with liver function damage in grade A and that in control 
group (P>0.05) and there were significant differences among 
groups with liver function damage in groups with grade A, 
B and C (P﹤0.05). The levels of ET-1 and CGRP increased 
significantly as the damage to liver function aggravated 
(Table 3).
Table 3
Levels of ET-1 and CGRP in plasma of patients in different Child-
Pugh Grades (ng/L).
Grade Cases       ET-1      CGRP
Control Group 60 27.41依14.72 38.08依17.49
Grade A 55 29.63依13.47 36.13依13.75
Grade B 89 40.54依16.75* 55.71依19.77*
Grade C 34 56.77依21.81* 78.32依26.89*
Compared with grade A, *P﹤0.05.
3.4. Relation between levels of ET-1 and CGRP and venous 
hemodynamics of patients with cirrhosis
  The levels of ET-1 and CGRP were in positive relation to 
the diameters of portal and splenic veins and quantity of 
splenic vein. The difference was statistically significant 
(P﹤0.01) (Table 4).
Table 4
Analysis of relation between vasoactive substances and hemodynamics 
of venous system.
Checking Items Dpv Vpv Qpv Dsv Vsv Qsv
ET-1 0.417** -0.342 0.254 0.479** 0.078 0.512**
CGRP 0.498** -0.305 0.286 0.528** 0.137 0.497**
**P﹤0.01.
4. Discussions 
  Hemodynamics in human body can change abnormally in 
the process of cirrhosis and such a change is relevant with 
two currently popular hypotheses-hypothesis of backward 
flow and hypothesis of forward flow[8, 9], both of which 
play an important role in the formation of cirrhosis portal 
hypertension[10,11]. So far, as to the measure of the blood flow 
of portal venous system, Color Doppler detection is of large 
value. In the study, through the detection of hemodynamics 
of portal vein by Color Doppler technique, it was found 
that as the Child-Pugh integral of liver function increased, 
the diameters of portal and splenic veins had the trend to 
dilate gradually while the blood flow in portal vein slowed 
down gradually and there were significantly differences in 
the degree of dilation among grade A, B and C. This is not 
totally same with the research results by Liu Mingtao and 
his colleagues[12]. In their study, they found that there were 
no remarkable differences in the degree of dilation of portal 
veins among grade A, B and C. Given the results that the 
values of Qsv/Qpv in group with cirrhosis in different grades 
were all higher than that in control group, the increase of 
blood flow in splenic vein plays an important role in the 
formation of portal hypertension of patients with cirrhosis. 
Therefore, the change in hemodynamics can be the index to 
assess the degree of hepatic parenchymal lesions as well as 
the effective index to diagnose portal hypertension[13,14].
  Some studies showed that the level of plasma ET-1 in 
patients with cirrhosis increased remarkably[15,16]. Our study 
results also indicated that the level of plasma ET-1 grew 
remarkably with the increase of child-pugh grade (P﹤0.05), 
suggesting that the level of plasma ET-1 was related to 
the serious degree of cirrhosis-growing gradually with the 
aggravation of the damage in liver function. The increase of 
ET-1 in patients with cirrhosis can raise the intra-hepatic 
vascular resistance and the portal pressure[17,18]. The level 
of plasma ET-1 is significantly related to the diameters of 
portal and splenic vein, indicating that it plays a certain role 
in the formation of portal hypertension. In addition, the study 
Table 1
Index results of hemodynamics of portal and splenic vein by color doppler ultrasound diagnosis.
Group n Dpv (cm) Vpv (cm/s) Qpv (mL/min) Dsv (cm) Vsv (cm/s)   Qsv (mL/min) Qsv/Qpv (%)
Control Group 60 1.12依0.12 23.84依3.17   904.32依197.36 0.75依0.21 17.22依3.18 278.14依45.12 30.7
Grade A 55  1.35依0.17*  17.66依3.45* 1011.45依247.14   0.92依0.25* 17.89依3.22 458.37依114.73** 45.3
Grade B 89   1.49依0.15△   13.97依2.47△ 1158.79依317.25     1.18依0.18△ 18.54依4.15 666.15依142.15△△ 57.5
Grade C 34   1.65依0.16▽   10.85依4.11▽ 1216.48依455.46     1.37依0.32▽ 18.76依2.47 847.29依245.69▽▽ 69.7
Compared with control group, *P﹤0.05, **P﹤0.01; Compared with grade A, △P﹤0.05, △△P﹤0.01; Compared with grade B, ▽P﹤0.05, ▽▽P﹤0.01.
Table 2
Expression level of ET-1 and CGRP in serum (ng/L).
Group Cases ET-1 CGRP
Control Group   60  27.41依21.31 38.08依19.89
Study Group 178    47.55依25.64**   63.91依29.47**
Group without Ascites   72  25.26依17.36 42.82依17.59
Group with Ascites 106     61.87依25.18△       85.09依23.47△△
Compared with control group, **P﹤0.01; Compared with group without ascites, △P﹤0.05, △△P﹤0.01.
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found that the level of CGRP is similar to that of ET-1 and 
the content in patients with cirrhosis is obviously higher than 
that in control group. The increase of CGRP may contribute 
to hyper-dynamic circulatory state, resulting in the increase 
of splanchnic blood flow and portal pressure[19]. The dilation 
of peripheral vessel and the abnormal distribution of blood 
volume lead to water-sodium retention, which is consistent 
with related reports[20,21]. The result that the level of ET-1 
and CGRP in patients with ascites is remarkably higher than 
that in cases without ascites indicates that high ET-1 and 
CGRP levels in patients with cirrhosis can lead to ascites 
through the dilation of peripheral vessels or the increase f 
portal pressure. Meanwhile, the level of CGRP is also related 
to the Child-Pugh grades of liver function. The above results 
show that ET-1 and CGRP may participate in the formation 
and maintenance of cirrhosis portal hypertension at the 
same time.
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